Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Inv. presentation
Quarterly results
Appointed director
|
|
ARGOS THERAPEUTICS INC (ARGS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/12/2018 |
4/A
| Katz Richard D (Vice President and CFO) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Sold 104,435 shares
@ $0.1647, valued at
$17.2k
|
|
| 01/12/2018 |
4/A
| Nicolette Charles A. (CSO and Vice President of R&D) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Sold 100,250 shares
@ $0.1646, valued at
$16.5k
|
|
| 01/12/2018 |
4/A
| Harrelson Lori R. (Vice President of Finance) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Sold 64,329 shares
@ $0.1647, valued at
$10.6k
|
|
| 01/12/2018 |
4/A
| Abbey Jeffrey D (President, CEO) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Sold 124,987 shares
@ $0.1646, valued at
$20.6k
|
|
| 06/15/2016 |
4/A
| Winterbottom Joan (Chief Human Resource Officer) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Granted 9,075 shares
@ $0 |
|
| 01/08/2016 |
4/A
| Abbey Jeffrey D (CEO) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Bought 5,000 shares
@ $2.4972, valued at
$12.5k
|
|
|
|